MauiDerm 2016

MauiDerm 2016

Melasma data strengthens therapeutic insightAgents that can attack melasma on multiple fronts include retinoids, glucosamine, hydroquinone, topical steroids, phytosterol, glycyrrhetinic acid, niacinamide, soybean extracts, retinoids, salicylic acid and liquirtin, an expert says.
Beyond the plaqueThere’s good evidence to suggest dermatologists who assess psoriasis patients should look beyond the plaques on the skin and consider not just the increased risk to the joints, but also the heart, mind and more.
Improving accuracy in NMSC diagnosisThe trend toward smaller biopsies may compromise the accuracy of dermatopathologists' diagnoses.
The implications in the future of biosimilarsThe FDA is evaluating biosimilar medications for use in the United States. The approval of these medications in the next few years could mean big changes for dermatologists and their psoriasis patients
2015 data expands skin cancer insightDr. Hensin Tsao, shares his insight on why skin cancer cases are increasing, how new immunotherapy treatments bring hope and why dermatologists should be on the look out for new challenges.
Clarifying ingenol labeling changesConcerns have been raised over an FDA Drug Safety Communication about spontaneously submitted adverse reactions in patients using this topical treatment for actinic keratosis as well as labeling changes that were implemented because of those reports. One expert offers perspective.
New products expand drug and device categoriesThe therapeutic armamentarium for dermatologic diseases continues to expand with the approval of several new products in 2015, and there appear to be more promising treatments on the horizon.
Considerations when examining NICU babies with blistering diseasesThe neonatal intensive care unit (NICU) can be a scary place for some dermatologists, pediatric dermatologist, Sheila Fallon Friedlander, M.D., told colleagues at the MauiDerm 2016 meeting this week. She provided two key messages aimed at enabling clinicians and the babies to get the help they need. Learn and find out that they are
Neurotoxin pipeline advances, stay wary of counterfeitsAs the neurotoxin market is set for expansion, so expands the market of counterfeit products. One expert reviews the innovative options coming up through the pipeline and cautions colleagues about the risks associated with counterfeits.
Zika virus, Chikungunya, Syphilis infections increase in newbornsMosquito-born virus, Zika, is expected to find its way to the United States. The result of infection can be devastating for pregnant women. Other viral infections being seen more commonly in infants are Chikungunya and syphilis. Learn more